Entity
  • Metacognitia

    Created in 2022
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    46
  • Activities

  • Technologies

  • Entity types

  • Location

    Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 5

  • Engaged corporates

    3
    2 0
  • Added in Motherbase

    3 months ago
Description
  • Value proposition

    Elevating Cardiovascular Interventional Imaging with Proprietary Hyper-Augmentation Technologies

    Metacognitia: pioneering the future of cardio-vascular imaging with advanced Hyper-Augmentation technology.

    Metacognitia is at the vanguard of MedTech innovation, introducing a groundbreaking hybrid of AI & BioPhysics technology tailored to redefine cardio-vascular imaging, driving to a new era with our advanced Hyper-Augmentation technology.

    Our innovations offer:

    ▶ Sharper diagnostics: elevating precision to new heights, providing crystal-clear insights into heart health.
    ▶ Predictive forecasts: empowering proactive care with accurate, early prognosis capabilities.
    ▶ Optimized interventional support: ensuring fine-tuned strategies for interventional procedures such as Optimal Stenting.

    Committed to safety and efficiency, our technology minimizes radiation exposure, setting new benchmarks in healthcare excellence.

    Recognized by BPI France with the DeepTech Label 2022 and as a laureate of French Tech Emergence 2023, Metacognitia is not just innovating, but also paving the future of patient care in cardiology.

    Join our transformative journey.

    Artificial Intelligence, SaaS, Deep Learning, Cardiovascular risk screening, Cardiovascular risk forecasting, Deeptech, Heart Imaging, Cathlab procedure support, and Healthtech

  • Original language

    Elevating Cardiovascular Interventional Imaging with Proprietary Hyper-Augmentation Technologies

    Metacognitia: pioneering the future of cardio-vascular imaging with advanced Hyper-Augmentation technology.

    Metacognitia is at the vanguard of MedTech innovation, introducing a groundbreaking hybrid of AI & BioPhysics technology tailored to redefine cardio-vascular imaging, driving to a new era with our advanced Hyper-Augmentation technology.

    Our innovations offer:

    ▶ Sharper diagnostics: elevating precision to new heights, providing crystal-clear insights into heart health.
    ▶ Predictive forecasts: empowering proactive care with accurate, early prognosis capabilities.
    ▶ Optimized interventional support: ensuring fine-tuned strategies for interventional procedures such as Optimal Stenting.

    Committed to safety and efficiency, our technology minimizes radiation exposure, setting new benchmarks in healthcare excellence.

    Recognized by BPI France with the DeepTech Label 2022 and as a laureate of French Tech Emergence 2023, Metacognitia is not just innovating, but also paving the future of patient care in cardiology.

    Join our transformative journey.

Corporate interactions BETA
Corporate TypeTweets Articles
DOCAPOSTE
DOCAPOSTE
IT services, IT Services and IT Consulting
DOCAPOSTE
IT services, IT Services and IT Consulting
Other

30 Nov 2023


CIC
CIC
Bank, Banking
CIC
Bank, Banking
Other

2 Dec 2023


WILCO
WILCO
Software Development
WILCO
Software Development
Other

30 Nov 2023


Similar entities
Loading...
Loading...
Social network dynamics